Medicalgorithmics S.A. (WSE:MDG)
Poland · Delayed Price · Currency is PLN 27.75
-0.25 (-0.89%)
Sep 4, 2026, 5:00 PM CET
Medicalgorithmics Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 276 | 334 | 168 | 304 | 122 | 94 | |
Market Cap Growth | -25.30% | 98.82% | -44.68% | 149.18% | 29.46% | -4.06% |
Enterprise Value | 299 | 351 | 166 | 280 | 121 | 125 |
Last Close Price | 27.75 | 33.60 | 16.90 | 30.55 | 12.26 | 18.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 146.05 | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 |
PS Ratio | 8.02 | 10.79 | 7.01 | 7.06 | 1.95 | 1.95 |
PB Ratio | 4.39 | 5.17 | 2.18 | 3.29 | 1.29 | 1.99 |
P/TBV Ratio | - | - | 24.81 | 11.82 | 3.88 | 571.23 |
P/FCF Ratio | - | - | - | - | 19.27 | - |
P/OCF Ratio | - | - | - | 1670.64 | 19.27 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.69 | 11.34 | 6.91 | 6.51 | 1.92 | 2.59 |
EV/EBITDA Ratio | - | - | - | 1989.11 | 7.26 | 5.67 |
EV/EBIT Ratio | - | - | - | - | 7.56 | 10.33 |
EV/FCF Ratio | - | - | - | - | 19.05 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.41 | 0.35 | 0.10 | 0.06 | 0.10 | 0.60 |
Debt / EBITDA Ratio | - | - | - | 4.95 | 0.53 | 1.05 |
Debt / FCF Ratio | - | - | - | - | 1.46 | - |
Net Debt / Equity Ratio | 0.37 | 0.31 | 0.03 | -0.21 | -0.18 | 0.35 |
Net Debt / EBITDA Ratio | -4.21 | -2.15 | -0.13 | -140.52 | -1.02 | 0.76 |
Net Debt / FCF Ratio | -45.80 | -9.28 | -0.17 | 64.75 | -2.67 | -1.02 |
Asset Turnover | 0.32 | 0.29 | 0.21 | 0.35 | 0.53 | 0.24 |
Inventory Turnover | 2.48 | 2.44 | 2.40 | 2.89 | - | - |
Quick Ratio | 0.78 | 0.88 | 1.45 | 2.76 | 4.59 | 0.88 |
Current Ratio | 1.11 | 1.30 | 2.49 | 3.52 | 5.45 | 0.91 |
Return on Equity (ROE) | -14.19% | -16.47% | -18.94% | -0.62% | 35.86% | -5.16% |
Return on Assets (ROA) | -3.51% | -5.70% | -9.40% | -0.14% | 8.44% | 3.80% |
Return on Invested Capital (ROIC) | -7.12% | -11.91% | -22.47% | -0.37% | 22.48% | 8.21% |
Return on Capital Employed (ROCE) | -6.30% | -10.20% | -17.70% | -0.30% | 14.30% | 16.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.49% | -3.49% | -9.56% | -0.19% | -9.72% | -191.65% |
FCF Yield | -0.18% | -0.64% | -7.86% | -0.10% | 5.19% | -17.39% |
Buyback Yield / Dilution | - | - | - | -74.58% | -25.38% | -9.88% |
Total Shareholder Return | - | - | - | -74.58% | -25.38% | -9.88% |